Alpha-Adrenoceptor Stimulated Lymphocytes Trigger the Mechanical Response of Vas Deferens: Participation of Arachidonic Acid Metabolites

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 1984 Aug 1

PMID 6148116

Authors

E S Borda

M M De Bracco

S Cangiani

M Finiasz

L Sterin-Borda

Affiliations

Soon will be listed here.

Abstract

Normal human lymphocytes (L) (8 X 10(5) ml-1) incubated with methoxamine (Me) (1 X 10(-7) M) (Me-L) triggered the mechanical response of the isolated vas deferens of the rat. L or Me alone did not modify this contractile activity at the concentrations cited above. Me alone (10(-6) to 10(-3) M) increased the tension of the vas. In the presence of L (8 X 10(5) ml-1) the dose-response curve to Me shifted to the left and the efficacy of Me was enhanced. Inhibitors of alpha 1-adrenoceptors completely blocked the reaction between Me and L while drugs that block alpha 1 and alpha 2-adrenoceptors reduced the reaction between Me-L and the vas deferens. Direct contact of Me-L with the assay organ was not necessary. Cell-free supernatants of L exposed to Me (Me-L supernatants) elicited the reaction in the same way as Me-L. This effect required the continuous presence of Me since dialyzed Me-L supernatants were inactive. Inhibitors of lipoxygenase(s) completely blocked the positive inotropic effect of Me-L or of Me-L supernatants. Inhibitors of cyclo-oxygenase potentiated this effect. These results suggest that Me reacts with alpha 1-adrenoceptors of L. From this reaction, soluble factors are released that potentiate the alpha-adrenoceptor stimulatory effect of Me on the vas deferens as a consequence of the release of oxidative products of the lipoxygenase/s pathway of arachidonic acid.

References

Vane J . Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971; 231(25):232-5. DOI: 10.1038/newbio231232a0. View

van Rossum J . Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn Ther. 1963; 143:299-330. View

Chisari F, Edgington T . Human T lymphocyte "E" rosette function. I. A process modulated by intracellular cyclic AMP. J Exp Med. 1974; 140(4):1122-6. PMC: 2139637. DOI: 10.1084/jem.140.4.1122. View

Michell R . Inositol phospholipids and cell surface receptor function. Biochim Biophys Acta. 1975; 415(1):81-47. DOI: 10.1016/0304-4157(75)90017-9. View

Hamberg M . On the formation of thromboxane B2 and 12l-hydroxy-5,8,10,14-eicosatetraenoic acid (12 ho-20:4) in tissues from the guinea pig. Biochim Biophys Acta. 1976; 431(3):651-4. DOI: 10.1016/0005-2760(76)90232-0. View

Ito M, Sless F, Parrott D . Evidence for control of complement receptor rosette-forming cells by alpha and beta-adrenergic agents. Nature. 1977; 266(5603):633-5. DOI: 10.1038/266633a0. View

Jones L, Michell R . Stimulus-response coupling at alpha-adrenergic receptors. Biochem Soc Trans. 1978; 6(3):673-88. DOI: 10.1042/bst0060673. View

Kelly J, Parker C . Effects of arachidonic acid and other unsaturated fatty acids on mitogenesis in human lymphocytes. J Immunol. 1979; 122(4):1556-62. View

Kelly J, Johnson M, Parker C . Effect of inhibitors of arachidonic acid metabolism on mitogenesis in human lymphocytes: possible role of thromboxanes and products of the lipoxygenase pathway. J Immunol. 1979; 122(4):1563-71. View

10.

Parker C, Stenson W, Huber M, Kelly J . Formation of thromboxane B2 and hydroxyarachidonic acids in purified human lymphocytes in the presence and absence of PHA. J Immunol. 1979; 122(4):1572-7. View

11.

Parker C, Kelly J, Falkenhein S, Huber M . Release of arachidonic acid from human lymphocytes in response to mitogenic lectins. J Exp Med. 1979; 149(6):1487-503. PMC: 2184892. DOI: 10.1084/jem.149.6.1487. View

12.

Burka J, Paterson N . The effects of SRS-A and histamine antagonists on antigen-induced contraction of guinea pig trachea. Eur J Pharmacol. 1981; 70(4):489-99. DOI: 10.1016/0014-2999(81)90360-5. View

13.

Langer S . Presynaptic regulation of the release of catecholamines. Pharmacol Rev. 1980; 32(4):337-62. View

14.

EXTON J . Molecular mechanisms involved in alpha-adrenergic responses. Mol Cell Endocrinol. 1981; 23(3):233-64. DOI: 10.1016/0303-7207(81)90123-4. View

15.

Krawietz W, Werdan K, Schober M, Erdmann E, Rindfleisch G, Hannig K . Different numbers of beta-receptors in human lymphocyte subpopulations. Biochem Pharmacol. 1982; 31(1):133-6. DOI: 10.1016/0006-2952(82)90252-0. View

16.

Borda E, del C Agostini M, GIMENO M, GIMENO A . Castration alters the stimulatory and inhibitory adrenergic influences on isolated rat vas deferens. Pharmacol Res Commun. 1981; 13(10):981-96. DOI: 10.1016/s0031-6989(81)80069-0. View

17.

Lappin D, Whaley K . Adrenergic receptors on monocytes modulate complement component synthesis. Clin Exp Immunol. 1982; 47(3):606-12. PMC: 1536447. View

18.

Henriksen O, Frey J . Control of the expression of interleukin-2 activity. Cell Immunol. 1982; 73(1):106-14. DOI: 10.1016/0008-8749(82)90439-7. View

19.

Farese R . The phosphatidate-phosphoinositide cycle: an intracellular messenger system in the action of hormones and neurotransmitters. Metabolism. 1983; 32(6):628-41. DOI: 10.1016/0026-0495(83)90035-5. View

20.

Bidart J, Motte P, Assicot M, Bohuon C, Bellet D . Catechol-O-methyltransferase activity and aminergic binding sites distribution in human peripheral blood lymphocyte subpopulations. Clin Immunol Immunopathol. 1983; 26(1):1-9. DOI: 10.1016/0090-1229(83)90167-8. View